Servicio de Microbiología Clínica. Hospital G.U. Gregorio Marañón
Institut Pasteur
París, FranciaPublicaciones en colaboración con investigadores/as de Institut Pasteur (19)
2020
-
Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey
Mycoses, Vol. 63, Núm. 5, pp. 420-429
2018
-
Prosthetic Valve Candida spp. Endocarditis: New Insights into Long-term Prognosis-The ESCAPE Study
Clinical Infectious Diseases, Vol. 66, Núm. 6, pp. 825-832
2016
-
ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 9, pp. 1-8
-
Pneumocystis jirovecii pneumonia: Still a concern in patients with haematological malignancies and stem cell transplant recipients
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 9
2014
-
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013
Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 5-26
-
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections
Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 76-98
-
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: Diseases caused by black fungi
Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 47-75
-
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others
Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 27-46
-
Multidisciplinary analysis of a nontoxigenic Clostridium difficile strain with stable resistance to metronidazole
Antimicrobial Agents and Chemotherapy, Vol. 58, Núm. 8, pp. 4957-4960
2011
-
European expert opinion on the management of invasive candidiasis in adults
Clinical Microbiology and Infection, Vol. 17, Núm. SUPPL. 5, pp. 1-12
2010
-
Identifying predictors of central nervous system disease in solid organ transplant recipientswith cryptococcosis
Transplantation, Vol. 89, Núm. 1, pp. 69-74
-
Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients
Clinical Infectious Diseases, Vol. 51, Núm. 9, pp. 1062-1069
2009
-
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis
Clinical Infectious Diseases, Vol. 49, Núm. 11, pp. 1721-1728
2008
-
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis
Antimicrobial Agents and Chemotherapy, Vol. 52, Núm. 2, pp. 735-738
-
Central nervous system cryptococcosis in solid organ transplant recipients: Clinical relevance of abnormal neuroimaging findings
Transplantation, Vol. 86, Núm. 5, pp. 647-651
2007
-
Cryptococcus neoformans in organ transplant recipients: Impact of calcineurin-inhibitor agents on mortality
Journal of Infectious Diseases, Vol. 195, Núm. 5, pp. 756-764
2005
-
Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome
Transplantation, Vol. 80, Núm. 8, pp. 1131-1133
-
An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients
Clinical Infectious Diseases, Vol. 40, Núm. 12, pp. 1756-1761
-
Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection
Transplantation, Vol. 80, Núm. 8, pp. 1033-1039